Fluorescence-guided surgery for liver cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a new way to remove liver cancer during surgery. A special dye called ICG is injected into the artery leading to the liver, which makes the tumor glow under a special camera, helping the surgeon remove just the right area. This study checks if this technique is both safe and effective for people with a common type of liver cancer (hepatocellular carcinoma).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old.
- You have been diagnosed with hepatocellular carcinoma (HCC), the most common type of liver cancer, and will have surgery to remove the tumor with a special dye that helps the surgeon see the cancer clearly.
- Your liver function is good enough (Child-Pugh class A or B) and you are healthy enough for surgery (ASA score I-III, ECOG 0-2).
- Your cancer has not spread into the main blood vessels of the liver or to other parts of the body.
- You have not had any prior treatment for liver cancer (like chemo, radiation, or TACE) or had liver surgery before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a combination approach—special, image-guided radiation and liver procedures—for liver cancer patients who cannot have surgery. It may help shrink tumors while protecting liver function by using planned, targeted treatment.
This trial tests a special dye that targets liver cancer cells to help surgeons see tumor edges more clearly during surgery. It may help ensure all cancer is removed in one operation.
This trial tests a new way to help surgeons see liver tumors more clearly during keyhole (laparoscopic) surgery. A special dye (ICG) is used with a camera to guide the surgeon in removing just the right part of the liver. It may lead to safer and more precise surgery for people with liver cancer.
This trial studies whether a special fluorescent dye that targets GPC3 can help surgeons find liver cancer more clearly during an operation. It may improve how accurately tumor tissue is identified while you have surgery for hepatocellular carcinoma.
This trial tests a new imaging technique that uses a special dye combined with a chemotherapy drug to help surgeons see and remove liver cancer more precisely during surgery. It is for people with a first-time, single liver tumor that is small and can be surgically removed.
This study tests using a special fluorescent dye (ICG) during surgery to help surgeons see and remove colon cancer more clearly. The dye highlights blood vessels and tissue, which may help ensure all cancer is removed safely.
Hear when a new Liver Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.